To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
Find out MoreDate | Time | Trade Prc | Volume | Buy/Sell | Value | |
---|---|---|---|---|---|---|
01-May-24 | 16:35:21 | 1.30 | 830 | Sell* | 1,079 | UT Uncrossing Trade |
01-May-24 | 15:48:54 | 1.3067 | 9,255 | Sell* | 12.09k | O Ordinary |
01-May-24 | 14:57:13 | 1.3067 | 199 | Sell* | 260.03 | O Ordinary |
01-May-24 | 14:56:45 | 1.306575 | 23,887 | Unknown* | 31.21k | O Ordinary |
01-May-24 | 13:54:42 | 1.30 | 208 | Sell* | 270.40 | A Automatic Execution |
01-May-24 | 13:54:42 | 1.30 | 5,000 | Sell* | 6,500 | A Automatic Execution |
01-May-24 | 13:01:26 | 1.3067 | 459 | Sell* | 599.78 | O Ordinary |
01-May-24 | 12:45:18 | 1.302568 | 4,800 | Unknown* | 6,252 | O Ordinary |
01-May-24 | 10:48:22 | 1.306201 | 5,351 | Unknown* | 6,989 | O Ordinary |
01-May-24 | 08:27:05 | 1.31 | 39,000 | Unknown* | 51.09k | O Ordinary Delayed publication |
01-May-24 | 09:01:01 | 1.3066 | 2,926 | Sell* | 3,823 | O Ordinary |